June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Quantifying Oxygen Exposure for Predicting Treatment-Requiring Retinopathy of Prematurity
Author Affiliations & Notes
  • Jimmy S Chen
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Jamie Anderson
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Aaron S Coyner
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Susan Ostmo
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Kemal Sonmez
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Deniz Erdogmus
    Electrical and Computer Engineering, Northeastern University, Boston, Massachusetts, United States
  • Cynthia McEvoy
    Pediatrics, Oregon Health & Science University, Portland, Oregon, United States
  • Brian Jordan
    Pediatrics, Oregon Health & Science University, Portland, Oregon, United States
  • Dmitry Dukovny
    Pediatrics, Oregon Health & Science University, Portland, Oregon, United States
  • Robert Schelonka
    Pediatrics, Oregon Health & Science University, Portland, Oregon, United States
  • Robison Vernon Paul Chan
    Ophthalmology, Illinois Eye and Ear Infirmary, Chicago, Illinois, United States
  • Praveer Singh
    Radiology, Massachusetts General Hospital, Boston, Massachusetts, United States
  • Jayashree Kalpathy-Cramer
    Radiology, Massachusetts General Hospital, Boston, Massachusetts, United States
  • Michael F Chiang
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States
  • J. Peter Campbell
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Footnotes
    Commercial Relationships   Jimmy Chen, None; Jamie Anderson, None; Aaron Coyner, None; Susan Ostmo, None; Kemal Sonmez, None; Deniz Erdogmus, None; Cynthia McEvoy, None; Brian Jordan, None; Dmitry Dukovny, None; Robert Schelonka, None; Robison Chan, Alcon (C), Genentech (F), Novartis (C), Phoenix Technology Group (S), Regeneron (F); Praveer Singh, None; Jayashree Kalpathy-Cramer, Genentech (F); Michael Chiang, Genentech (F), Intelretina (I), Novartis (C); J. Peter Campbell, Genentech (F)
  • Footnotes
    Support  Unrestricted funding from Research to Prevent Blindness, National Science Foundation, and the National Institutes of Health (Grants T15LM007088, R01EY19474, R01EY031331, K12EY027720, and P30EY10572)
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3246. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jimmy S Chen, Jamie Anderson, Aaron S Coyner, Susan Ostmo, Kemal Sonmez, Deniz Erdogmus, Cynthia McEvoy, Brian Jordan, Dmitry Dukovny, Robert Schelonka, Robison Vernon Paul Chan, Praveer Singh, Jayashree Kalpathy-Cramer, Michael F Chiang, J. Peter Campbell; Quantifying Oxygen Exposure for Predicting Treatment-Requiring Retinopathy of Prematurity. Invest. Ophthalmol. Vis. Sci. 2021;62(8):3246.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Oxygen exposure and extreme prematurity are among two of the strongest risk factors for severe retinopathy of prematurity (ROP), however current screening criteria focuses on birth weight and gestational age (GA) at birth. Improved risk models may reduce the screening burden for low-risk infants and improve disease detection for infants with the most severe ROP, including aggressive posterior ROP (APROP). The purpose of this study was to evaluate the additive predictive value of quantifying oxygen exposure in early life for detection of treatment-requiring (TR-) ROP and APROP.

Methods : Demographics and oxygen exposure parameters were manually extracted from the electronic health record for each week of life (WOL) for 244 infants, 33 of whom eventually developed TR-ROP and 5 of whom developed APROP. Cumulative minimum, maximum, and total fraction of inspired oxygen (FiO2) were calculated by summing values per WOL. Using 5-fold cross-validation, models using various combinations of birthweight, GA and FiO2 were trained using random forest tuned with randomized grid search for prediction of future TR-ROP. Performance was evaluated using mean area under the receiver operating curve (AUROC) and precision-recall curve (AUPRC). To test the predictive value of oxygen exposure for APROP, cumulative minimum FiO2 exposure was also plotted against eventual ROP outcome (no treatment, TR-ROP without APROP, or APROP) and an AUROC score was generated.

Results : On 5-fold cross-validation, the models trained on GA + cumulative minimum FiO2 exposure had slightly higher performance than the models trained on GA alone (Figure 1, mean AUROC = 0.93±0.06 vs. 0.91±0.06, AUPRC = 0.76±0.08 vs. 0.74±0.13 respectively) for TR-ROP. For APROP, the AUROC of cumulative minimum FiO2 exposure was 0.92 with clear dose response between oxygen exposure and level of ROP (Figure 2).

Conclusions : Quantitative oxygen exposure variables can be extracted and used to augment the identification of high-risk infants for developing TR-ROP, including APROP. Future work should focus on prospectively evaluating models that account for oxygen exposure.

This is a 2021 ARVO Annual Meeting abstract.

 

5-Fold cross-validation curves for combinations of random forest models accounting for gestational age and oxygen exposure

5-Fold cross-validation curves for combinations of random forest models accounting for gestational age and oxygen exposure

 

Box plot of oxygen exposure vs. ROP outcome

Box plot of oxygen exposure vs. ROP outcome

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×